Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios


suck pdf from google scholar
unlimited free pdf from europmc32282949    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32282949 :   free
PDF vom PMID32282949

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Hematological findings and complications of COVID-19 #MMPMID32282949
  • Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
  • Am J Hematol 2020[Jul]; 95 (7): 834-847 PMID32282949show ga
  • COVID-19 is a systemic infection with a significant impact on the hematopoietic system and hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with prognostic potential. Neutrophil/lymphocyte ratio and peak platelet/lymphocyte ratio may also have prognostic value in determining severe cases. During the disease course, longitudinal evaluation of lymphocyte count dynamics and inflammatory indices, including LDH, CRP and IL-6 may help to identify cases with dismal prognosis and prompt intervention in order to improve outcomes. Biomarkers, such high serum procalcitonin and ferritin have also emerged as poor prognostic factors. Furthermore, blood hypercoagulability is common among hospitalized COVID-19 patients. Elevated D-Dimer levels are consistently reported, whereas their gradual increase during disease course is particularly associated with disease worsening. Other coagulation abnormalities such as PT and aPTT prolongation, fibrin degradation products increase, with severe thrombocytopenia lead to life-threatening disseminated intravascular coagulation (DIC), which necessitates continuous vigilance and prompt intervention. So, COVID-19 infected patients, whether hospitalized or ambulatory, are at high risk for venous thromboembolism, and an early and prolonged pharmacological thromboprophylaxis with low molecular weight heparin is highly recommended. Last but not least, the need for assuring blood donations during the pandemic is also highlighted.
  • |*Betacoronavirus[MESH]
  • |Anticoagulants/therapeutic use[MESH]
  • |Biomarkers[MESH]
  • |Blood Coagulation Tests[MESH]
  • |Blood Donors/supply & distribution[MESH]
  • |C-Reactive Protein/analysis[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Testing[MESH]
  • |Clinical Laboratory Techniques[MESH]
  • |Coronavirus Infections/*blood/complications/diagnosis[MESH]
  • |Cytokine Release Syndrome/blood/etiology[MESH]
  • |Cytokines/blood[MESH]
  • |Disseminated Intravascular Coagulation/blood/etiology[MESH]
  • |Early Diagnosis[MESH]
  • |Ferritins/blood[MESH]
  • |Fibrin Fibrinogen Degradation Products/analysis[MESH]
  • |Humans[MESH]
  • |Lymphopenia/*etiology[MESH]
  • |Meta-Analysis as Topic[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*blood/complications/diagnosis[MESH]
  • |Risk[MESH]
  • |SARS-CoV-2[MESH]
  • |Thrombophilia/blood/drug therapy/*etiology[MESH]
  • |Venous Thromboembolism/blood/etiology/prevention & control[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    834 7.95 2020